Sam Berns was my friend. With the wisdom of a sage, he inspired me and many others about how to make the most of life. Afflicted with the rare disease called progeriahis body aged at a rapid rate, and he died of heart failure at just 17, a brave life cut much too short. My […]
Deshawn “DJ” Chow waited a year to receive a treatment that could change his life. The 19-year-old was born with sickle cell disease, which makes his red blood cells crescent-shaped and sticky. The misshapen cells build up and block blood vessels, cutting off oxygen to parts of the body and causing episodes of excruciating pain. […]
Nature, Published online: 17 December 2024; doi:10.1038/d41586-024-04102-w Gene-editing technologies for cancer and blood disorders are maturing a little more than a year after the first CRISPR drug was approved.
Increasingly, agricultural scientists in Asia and Africa are using the gene-editing tool CRISPR to develop disease-resistant, high-yield crop varieties. Many, especially those in government research laboratories, are underestimating the importance of the patent and licensing rules that surround tools such as CRISPR. Access the most recent journalism from Nature’s award-winning team Explore the latest features […]
In 2025, we will see AI and machine learning begin to amplify the impact of Crispr genome editing in medicine, agriculture, climate change, and the basic research that underpins these fields. It’s worth saying upfront that the field of AI is awash with big promises like this. With any major new technological advance there is […]
Hello Nature readers, would you like to get this Briefing in your inbox free every day? Sign up here. Two changes make tomatoes tastier.Credit: Majdi Fathi/NurPhoto/Getty Editing a pair of genes in tomato plants (Solanum lycopersicum) boosts the fruit’s sugar levels by up to 30%, with no difference in size. Cultivated tomatoes today are up […]
Nearly a year after its approval, the first medical treatment that uses the Nobel Prize–winning technology Crispr is now being given to patients. Called Casgevy, the gene-editing treatment is for people with sickle cell disease and a related blood disorder called beta thalassemia. UK regulators approved the treatment in November 2023, followed by the US […]
